B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4119-4128

  Schneider, Raphael ^a   Mohebiany, Alma Nazlie ^a   Ifergan, Igal ^a   Beauseigle, Diane ^a   Duquette, Pierre ^a,b   Prat, Alexandre ^a,b   Arbour, Nathalie ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; GRANZYME B; INTERLEUKIN 15;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CELL STRESS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME SYNTHESIS; GLIA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; B-LYMPHOCYTES; CELL SEPARATION; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80054774245     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100885     Document Type: Article

References (60)

1. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747. (Pubitemid 40563183)
2. Mars, L. T., P. Saikali, R. S. Liblau, and N. Arbour. 2011. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim. Biophys. Acta 1812: 151-161.
3. + T cells in multiple sclerosis. Ann. Neurol. 66: 132-141.
4. Junker, A., J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann, H. Wekerle, E. Meinl, R. Hohlfeld, and K. Dornmair. 2007. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130: 2789-2799. (Pubitemid 350033964)
5. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
6. Höftberger, R., F. Aboul-Enein, W. Brueck, C. Lucchinetti, M. Rodriguez, M. Schmidbauer, K. Jellinger, and H. Lassmann. 2004. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14: 43-50. (Pubitemid 38200588)
7. Neumann, H., I. M. Medana, J. Bauer, and H. Lassmann. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25: 313-319. (Pubitemid 34667013)
8. + T cells in a spontaneous model of demyelinating disease. J. Immunol. 177: 2403-2411.
9. Ip, C. W., A. Kroner, M. Bendszus, C. Leder, I. Kobsar, S. Fischer, H. Wiendl, K. A. Nave, and R. Martini. 2006. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J. Neurosci. 26: 8206-8216. (Pubitemid 44315145)
10. Saxena, A., J. Bauer, T. Scheikl, J. Zappulla, M. Audebert, S. Desbois, A. Waisman, H. Lassmann, R. S. Liblau, and L. T. Mars. 2008. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181: 1617-1621.
11. Alves, N. L., B. Hooibrink, F. A. Arosa, and R. A. van Lier. 2003. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102: 2541-2546. (Pubitemid 37193593)
12. Budagian, V., E. Bulanova, R. Paus, and S. Bulfone-Paus. 2006. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17: 259-280. (Pubitemid 44038618)
13. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Rα recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537-547. (Pubitemid 35351500)
14. McInnes, I. B., J. al-Mughales, M. Field, B. P. Leung, F. P. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2: 175-182. (Pubitemid 26057554)
15. Mention, J. J., M. Ben Ahmed, B. Bègue, U. Barbe, V. Verkarre, V. Asnafi, J. F. Colombel, P. H. Cugnenc, F. M. Ruemmele, E. McIntyre, et al. 2003. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125: 730-745. (Pubitemid 37070691)
16. Sakai, T., K. Kusugami, H. Nishimura, T. Ando, T. Yamaguchi, M. Ohsuga, K. Ina, A. Enomoto, Y. Kimura, and Y. Yoshikai. 1998. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 114: 1237-1243. (Pubitemid 28243910)
17. Rentzos, M., C. Cambouri, A. Rombos, C. Nikolaou, M. Anagnostouli, A. Tsoutsou, A. Dimitrakopoulos, N. Triantafyllou, and D. Vassilopoulos. 2006. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 241: 25-29. (Pubitemid 43112512)
18. Blanco-Jerez, C., J. F. Plaza, J. Masjuan, L. M. Orensanz, and J. C. Alvarez-Cermeño. 2002. Increased levels of IL-15 mRNA in relapsing - remitting multiple sclerosis attacks. J. Neuroimmunol. 128: 90-94. (Pubitemid 34722368)
19. Kivisäkk, P., D. Matusevicius, B. He, M. Söderström, S. Fredrikson, and H. Link. 1998. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 111: 193-197. (Pubitemid 28062797)
20. Vaknin-Dembinsky, A., S. D. Brass, R. Gandhi, and H. L. Weiner. 2008. Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. J. Neuroimmunol. 195: 135-139.
21. Pashenkov, M., M. Mustafa, P. Kivisäkk, and H. Link. 1999. Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis. Scand. J. Immunol. 50: 302-308. (Pubitemid 29399904)
22. Saikali, P., J. P. Antel, C. L. Pittet, J. Newcombe, and N. Arbour. 2010. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J. Immunol. 185: 5693-5703.
23. Arbour, N., A. Holz, J. C. Sipe, D. Naniche, J. S. Romine, J. Zyroff, and M. B. Oldstone. 2003. A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis. J. Neuroimmunol. 137: 197-209. (Pubitemid 36351582)
24. Arbour, N., R. Lapointe, P. Saikali, E. McCrea, T. Regen, and J. P. Antel. 2006. A new clinically relevant approach to expand myelin specific T cells. J. Immunol. Methods 310: 53-61. (Pubitemid 43375975)
25. +T lymphocytes and promotes their development into Tc1 cells. Eur. J. Immunol. 41: 47-59.
26. Prat, A., K. Biernacki, S. Pouly, J. Nalbantoglu, R. Couture, and J. P. Antel. 2000. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropathol. Exp. Neurol. 59: 896-906.
27. Hartmann, G., and A. M. Krieg. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164: 944-953.
28. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 2499-2504. (Pubitemid 26104798)
29. Peters, A. L., L. L. Stunz, and G. A. Bishop. 2009. CD40 and autoimmunity: the dark side of a great activator. Semin. Immunol. 21: 293-300.
30. Teleshova, N., W. Bao, P. Kivisäkk, V. Ozenci, M. Mustafa, and H. Link. 2000. Elevated CD40 ligand expressing blood T-cell levels in multiple sclerosis are reversed by interferon-β treatment. Scand. J. Immunol. 51: 312-320. (Pubitemid 30151516)
31. Musso, T., L. Calosso, M. Zucca, M. Millesimo, D. Ravarino, M. Giovarelli, F. Malavasi, A. N. Ponzi, R. Paus, and S. Bulfone-Paus. 1999. Human monocytes constitutively express membrane-bound, biologically active, and interferon-γ-upregulated interleukin-15. Blood 93: 3531-3539. (Pubitemid 29220921)
32. Ifergan, I., K. Wosik, R. Cayrol, H. Kébir, C. Auger, M. Bernard, A. Bouthillier, R. Moumdjian, P. Duquette, and A. Prat. 2006. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ann. Neurol. 60: 45-55.
33. Kebir, H., I. Ifergan, J. I. Alvarez, M. Bernard, J. Poirier, N. Arbour, P. Duquette, and A. Prat. 2009. Preferential recruitment of interferon-γ- expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66: 390-402.
34. Prat, A., K. Biernacki, K. Wosik, and J. P. Antel. 2001. Glial cell influence on the human blood-brain barrier. Glia 36: 145-155. (Pubitemid 33055903)
35. Wang, T., R. Allie, K. Conant, N. Haughey, J. Turchan-Chelowo, K. Hahn, A. Rosen, J. Steiner, S. Keswani, M. Jones, et al. 2006. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J. 20: 1209-1211.
36. Giuliani, F., C. G. Goodyer, J. P. Antel, and V. W. Yong. 2003. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 171: 368-379. (Pubitemid 36745310)
37. McLaurin, J., G. C. Trudel, I. T. Shaw, J. P. Antel, and N. R. Cashman. 1995. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J. Neurobiol. 26: 283-293.
38. +-ATPase, on CTL-mediated cytotoxicity. J. Immunol. 153: 3938-3947.
39. Hart, G., T. Avin-Wittenberg, and I. Shachar. 2008. IL-15 regulates immature B-cell homing in an Ly49D-, IL-12-, and IL-18-dependent manner. Blood 111: 50-59.
40. Bo, H., X. Q. Wei, H. Dong, Y. Zhang, P. Lv, W. Liu, A. Koutoulaki, and X. M. Gao. 2009. Elevated expression of transmembrane IL-15 in immune cells correlates with the development of murine lupus: a potential target for immunotherapy against SLE. Scand. J. Immunol. 69: 119-129.
41. Tsukamoto, K., Y. C. Huang, W. C. Dorsey, B. Carns, and V. Sharma. 2006. Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines. Clin. Exp. Immunol. 146: 559-566. (Pubitemid 44722176)
42. Jagannathan, M., H. Hasturk, Y. Liang, H. Shin, J. T. Hetzel, A. Kantarci, D. Rubin, M. E. McDonnell, T. E. Van Dyke, L. M. Ganley-Leal, and B. S. Nikolajczyk. 2009. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J. Immunol. 183: 7461-7470.
43. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504. (Pubitemid 36857820)
44. Mita, Y., K. Dobashi, K. Endou, T. Kawata, Y. Shimizu, T. Nakazawa, and M. Mori. 2002. Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4. Immunol. Lett. 81: 71-75. (Pubitemid 34159043)
45. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688. (Pubitemid 351240747)
46. Cross, A. H., J. L. Stark, J. Lauber, M. J. Ramsbottom, and J. A. Lyons. 2006. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 180: 63-70. (Pubitemid 44767709)
47. Bar-Or, A., L. Fawaz, B. Fan, P. J. Darlington, A. Rieger, C. Ghorayeb, P. A. Calabresi, E. Waubant, S. L. Hauser, J. Zhang, and C. H. Smith. 2010. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol. 67: 452-461.
48. Ota, N., M. Takase, H. Uchiyama, S. K. Olsen, and O. Kanagawa. 2010. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation. J. Immunol. 185: 6041-6048.
49. Marshall, H. D., A. L. Prince, L. J. Berg, and R. M. Welsh. 2010. IFN-αβ and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J. Immunol. 185: 1419-1428.
50. Perera, L. P., C. K. Goldman, and T. A. Waldmann. 1999. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162: 2606-2612. (Pubitemid 29309280)
51. Oppenheimer-Marks, N., R. I. Brezinschek, M. Mohamadzadeh, R. Vita, and P. E. Lipsky. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J. Clin. Invest. 101: 1261-1272. (Pubitemid 28145242)
52. Nieto, M., M. A. del Pozo, and F. Sánchez-Madrid. 1996. Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur. J. Immunol. 26: 1302-1307. (Pubitemid 26001065)
53. Stoklasek, T. A., K. S. Schluns, and L. Lefrançois. 2006. Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177: 6072-6080. (Pubitemid 44628822)
54. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrançois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168: 4827-4831. (Pubitemid 34495942)
55. + T cell attack. Glia 58: 469-480.
56. Niland, B., G. Miklossy, K. Banki, W. E. Biddison, L. Casciola-Rosen, A. Rosen, D. Martinvalet, J. Lieberman, and A. Perl. 2010. Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients. J. Immunol. 184: 4025-4032.
57. Rensing-Ehl, A., U. Malipiero, M. Irmler, J. Tschopp, D. Constam, and A. Fontana. 1996. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur. J. Immunol. 26: 2271-2274. (Pubitemid 26297532)
58. Wang, T., M. H. Lee, T. Johnson, R. Allie, L. Hu, P. A. Calabresi, and A. Nath. 2010. Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers. J. Neurosci. 30: 5020-5027.
59. Chowdhury, D., and J. Lieberman. 2008. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26: 389-420. (Pubitemid 351611623)
60. Baslund, B., N. Tvede, B. Danneskiold-Samsoe, P. Larsson, G. Panayi, J. Petersen, L. J. Petersen, F. J. Beurskens, J. Schuurman, J. G. van de Winkel, et al. 2005. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum. 52: 2686-2692. (Pubitemid 41369096)